- Home
- STC vs QURE Comparison
STC vs QURE Comparison
Compare STC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STC
- QURE
- Stock Information
- Founded
- STC 1893
- QURE 1998
- Country
- STC United States
- QURE Netherlands
- Employees
- STC N/A
- QURE N/A
- Industry
- STC Specialty Insurers
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- STC Finance
- QURE Health Care
- Exchange
- STC Nasdaq
- QURE Nasdaq
- Market Cap
- STC 2.1B
- QURE 1.9B
- IPO Year
- STC N/A
- QURE 2007
- Fundamental
- Price
- STC $77.80
- QURE $27.54
- Analyst Decision
- STC Buy
- QURE Strong Buy
- Analyst Count
- STC 2
- QURE 13
- Target Price
- STC $77.50
- QURE $62.33
- AVG Volume (30 Days)
- STC 173.6K
- QURE 4.7M
- Earning Date
- STC 10-22-2025
- QURE 11-10-2025
- Dividend Yield
- STC 2.72%
- QURE N/A
- EPS Growth
- STC 69.60
- QURE N/A
- EPS
- STC 3.60
- QURE N/A
- Revenue
- STC $2,796,513,000.00
- QURE $15,751,000.00
- Revenue This Year
- STC $17.67
- QURE N/A
- Revenue Next Year
- STC $10.14
- QURE $229.18
- P/E Ratio
- STC $21.42
- QURE N/A
- Revenue Growth
- STC 16.09
- QURE N/A
- 52 Week Low
- STC $56.39
- QURE $5.86
- 52 Week High
- STC $78.61
- QURE $71.50
- Technical
- Relative Strength Index (RSI)
- STC 67.91
- QURE 33.96
- Support Level
- STC $70.86
- QURE $26.76
- Resistance Level
- STC $78.61
- QURE $29.99
- Average True Range (ATR)
- STC 2.32
- QURE 2.67
- MACD
- STC 0.64
- QURE -0.10
- Stochastic Oscillator
- STC 86.18
- QURE 37.32
About STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.